Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of vaginal misoprostol with oxytocin for termination of pregnancy with intrauterine fetal death
IRCT20181218042033N2Phase 2Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of misoprostol and oxytocin in stillbirth (2 arms), sponsored by Hormozgan University of Medical Sciences. Started Mar 2019; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
stillbirth
Beyond the preview
Go deeper on IRCT20181218042033N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181218042033N2.